LOW BIREFRINGENCE FERROELECTRIC LIQUID CRYSTAL MIXTURES

Abstract

A low birefringence ferroelectric liquid crystal (FLC) mixture composed of at least two components shows birefringence in the range 0.05 to 0.14, which is suitable for the modern display and photonic devices. The cell gap can be tuned from 1.5 m to 4 m to reduces the fabrication complexity and chromatic distortion by electro-optical modulation. The FLC mixtures can be employed in a wide temperature range. The characteristics of the said FLC mixture can be tuned by tuning the concentration of the constituents of the mixture. The helical pitch of the FLC mixtures can be varied from 100 nm to 10 m. A smectic tilt angle can be varied between 17 to 45 and the spontaneous polarization can be tuned over a wide range to meet requirements of different electro-optical modes, and the FLC mixture is applicable for a wide variety of electro-optical effects.

Claims

1. A low birefringence ferroelectric liquid crystal (FLC) mixture, comprising at least a first component comprising a thermotropic liquid crystal having a birefringence n value of 0.02 to 0.25 and a second component comprising a low birefringence material having a birefringence n value of 0.02 to 0.1 of the formula: ##STR00141## wherein: n and m are independently 0, 1 or 2; R1, R2, R3 and R4 are independently absent or selected from aromatic, heteroaromatic, 1,4-cyclohexylidene, 1,4-cyclohexenylidene, 1,3-dioxolane, and a chiral or achiral polycyclic aliphatic fragment, optionally, where the polycyclic fragment is substituted with one or more halogens, where a plurality of R1, R2, R3 and R4 are condensed, optionally where H atoms are independently replaced with F atoms; A1 and A2 are independently selected from a single CC bond, O, S and an ester functional group; B1, B2 and B3 are independently absent or selected from a CC single bond, an ester functional group, C(O)(CH.sub.2).sub.pC(O)O, (CX.sub.2).sub.pCH.sub.2C(O)O and C(O)0(CH.sub.2).sub.pC(O)O where X is independently H or halogen and p is 2-11; and W1 and W2 are independently selected from n-alkyl, chiral or achiral branched alkyl, chiral or achiral alkenyl, where, optionally, one or more hydrogen is independently replaced by F and one or more CH.sub.2 is independently replaced with O, or CHCH groups provided that two O atoms are not linked to form a peroxide.

2. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the aromatic and heteroaromatic rings of R1, R2, R3, or R4 are not conjugated or cross-conjugated to one another.

3. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the aromatic and heteroaromatic of R1, R2, R3, or R4 are conjugation with a single double bond of type CZ, where Z is C, N, or chalkogene.

4. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein at least one of W.sub.1 and/or W.sub.2 is chiral.

5. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the thermotropic liquid crystal is selected from nematic, cholesteric, smectic-A, smectic-B, and smectic-C, wherein the ferroelectric liquid crystal (FLC) mixture possesses a birefringence in a range of n value of 0.02 to 0.25.

6. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the second component has the structure: ##STR00142## where A1 is OC(O) and A2 is COO.

7. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the second component has the structure: ##STR00143## where: R1 and R2 or R3 and R4 are independently selected from 1,4-cyclohexylidene, 1,4-cyclohexenylidene, 1,3-dioxolane, and the polycyclic aliphatic fragment; A1, A2 are independently CC single bond or O; W1 is chiral branched alkyl or chiral alkenyl; and W2 is n-alkyl.

8. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the second component has the structure: ##STR00144## wherein: n=0, 1; R1 is 1,4-cyclohexylidene; A1 is CC bond single or O; W1 is chiral branched alkyl or chiral alkenyl; and W2 is an n-alkyl group.

9. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the second component has the structure: ##STR00145## wherein: n=0, 1; A1 is CC single bond or O.

10. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the second component has the structure: ##STR00146## wherein: n=0, 1; R1 are 1,4-phenylene or 1,4-cyclohexylidene ring; A1 is CC single bond or O; W1 is chiral branched alkyl or chiral alkenyl; and W2 is n-alkyl group, and wherein the thermotropic liquid crystal is a smectic liquid crystal and the birefringence n value is 0.12 to 0.25.

11. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the second component has the structure: ##STR00147## wherein: k=0, 1; R3 is 1,4-phenylene or 1,4-cyclohexylidene; A1 and A2 are single CC bond, O, and ester functional group, and wherein the thermotropic liquid crystal is a smectic liquid crystal and the birefringence n value is 0.12 to 0.25.

12. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the second component has the structure: ##STR00148## wherein: A1 and A2 are ester functional groups, and the thermotropic liquid crystal is a smectic liquid crystal and the birefringence n value is 0.2 to 0.25.

13. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the second component has the structure: ##STR00149## wherein: n is 0, 1; is a carbon-carbon single bond or carbon-carbon double bond; X1 and X2 are independently H or halogen; B1 is O or ester functional group; R1 is 1,4-phenylene or 1,4-cyclohexylidene; and A1 is CC single bond or O, and wherein the thermotropic liquid crystal has the birefringence n value of 0.02 to 0.1.

14. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the low birefringence ferroelectric liquid crystal (FLC) mixture has a wide phase transitions temperature range of more than 100 C.

15. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the ferroelectric liquid crystal mixture displays a smectic-C tilt angle of 19 to 45 at 20 C. to 100 C.

16. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the ferroelectric liquid crystal mixture displays a smectic-C tilt angle of 22.5 at 20 C. to 100 C.

17. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the ferroelectric liquid crystal mixture displays a smectic-C tilt angle of 37 at 20 C. to 100 C.

18. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the ferroelectric liquid crystal mixture comprises at least one chiral component and displays a helical pitch of 40 nm to 10 m.

19. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the thermotropic liquid crystal displays a smectic-C with a helical pitch less than 300 nm.

20. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein the thermotropic liquid crystal displays a smectic-C with a helical pitch greater than 700 nm.

21. The low birefringence ferroelectric liquid crystal (FLC) mixture according to claim 1, wherein W1 and W2 are chiral branched alkyls having at least one CF.sub.3 substituent at a chiral center.

22. The low birefringence ferroelectric liquid crystal mixture according to claim 1, wherein the said ferroelectric liquid crystal mixture has a helical pitch in a smectic-C phase of 0.7 m or higher.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0011] FIG. 1 shows a schematic diagram for the relationship between the amount of conjugated aromatic rings in LC core molecular structure, the resulting birefringence, and the probability of SmC phase formation, where the required cell thickness according to eq. 1 are useful as a guide at =550 nm.

[0012] FIG. 2 shows phase diagrams for 2-(4-(heptyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5-O7) with nematic 4-hexyloxyphenyl-4-buthylcyclohexyl carboxylate (4-CHA-6), according to an embodiment of the invention.

[0013] FIG. 3 shows phase diagrams for 2-(4-(octyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5-O8) with 4-octyloxyphenyl-4-buthylcyclohexyl carboxylate (4-CHA-O8) according to an embodiment of the invention.

[0014] FIG. 4 shows phase diagrams for 2-(4-(heptyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5-O7) with a mixture of 4-alkoxyphenyl-4-alkylcyclohexyl carboxylate according to an embodiment of the invention.

[0015] FIG. 5 shows fragments of phase diagrams for 2-(4-(octyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5-O8) with 4-propyl-[1,1-bi(cyclohexan)]-4-yl 4-propylcyclohexanecarboxylate (DCHA-3), according to an embodiment of the invention.

[0016] FIG. 6 shows fragments of phase diagrams for phase diagrams of the 2-(4-(octyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5-O8) with lower birefringence compoundspropanoylcholesterol (Chol3), according to an embodiment of the invention.

[0017] FIG. 7 shows fragments of phase diagrams for 2-(4-(octyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5-O8) with lower birefringence compoundsnonanoylcholesterol (Chol9), according to an embodiment of the invention.

[0018] FIG. 8 shows fragments of phase diagrams for 2-(4-(octyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5-O8) with lower birefringence compounds3-((2-trifluoromethyl)-heptyl)-cholesterol (Chol-TF8), according to an embodiment of the invention.

[0019] FIG. 9 shows fragments of phase diagrams for 2-(4-(octyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5-O8) with lower birefringence compounds3-(2-fluorooctyl)-cholesterol (Chol-2F-8), according to an embodiment of the invention.

[0020] FIG. 10 shows fragments of phase diagrams for 2-(4-(decyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5-O10) with lower birefringence compounds3-(4-pentylcyclohexylcarbonyl)-cholesterol (Chol-TF8), according to an embodiment of the invention.

[0021] FIG. 11 shows phase diagrams that illustrate the effect of chiral compounds on phase transitions of FLC materials, according to an embodiment of the invention.

[0022] FIG. 12 shows structures of exemplary compounds that can reduce n in the mixtures with compounds of PAC type esters, according to an embodiment of the invention.

[0023] FIG. 13 shows structures of various cholesterol derivatives that can reduce n in mixtures with compounds of PAC type, according to an embodiment of the invention.

[0024] FIG. 14 shows phase diagrams of 2-(4-(octyloxy)phenyl)-2-oxoethyl 4-pentylcyclo-hexanecarboxylate (PAC-5-O8) with 2-(4octyloxyphenyl)-5-nonyloxypyrimidine (90-PP-O8), according to an embodiment of the invention.

[0025] FIG. 15 shows phase diagrams for the influence of chiral compounds on phase transitions of FLC materials, according to an embodiment of the invention.

[0026] FIG. 16 shows phase diagrams for mixtures of various homologs of PAC series, according to an embodiment of the invention.

[0027] FIG. 17 shows phase diagrams for mixtures of various homologs of PAC series, with phase transitions Cr-SMC obtained upon heating and others upon cooling, according to an embodiment of the invention.

[0028] FIG. 18 shows phase diagrams for mixtures of various homologs of PAC series, according to an embodiment of the invention.

[0029] FIG. 19 shows phase diagrams for mixtures of various homologs of PAC series, according to an embodiment of the invention.

[0030] FIG. 20 shows phase diagrams for mixtures of various homologs of PAC series, according to an embodiment of the invention.

[0031] FIG. 21 shows phase diagrams for mixtures of various homologs of PAC series, according to an embodiment of the invention.

[0032] FIG. 22 shows phase diagrams for the influence of chiral compounds on phase transitions of FLC materials, according to an embodiment of the invention.

[0033] FIG. 23 shows a plot of the electro-optical response as a function of the voltage for mixture 7-191-M3 that resembles typical ESHFLCs with a cell gap of 3 m, according to an embodiment of the invention.

[0034] FIG. 24 shows an optical microscopic image of the texture of a low n FLC, an ESHFLC, example 7-191-M3, under cross polarization in the absence of the electric field and with a cell gap of 3 m, according to an embodiment of the invention.

[0035] FIG. 25 shows photographs of a low n ESHFLC display cell in the bright state (a) and the dark state (b) for a FLC layer thickness of 3 m, according to an embodiment of the invention.

[0036] FIG. 26 shows a plot of the electro-optical switching time as a function of applied voltage for the mixture 7-130-M3 with a cell gap of 3 m that resembles a surface stabilize ferroelectric liquid crystals, according to an embodiment of the invention.

[0037] FIG. 27 shows a microscopic image of FLC7-130-M3 in a SSFLC mode with cell gap of 3 m, according to an embodiment of the invention.

[0038] FIG. 28 shows a plot of the temperature dependence of the tilt angle of two low n FLC mixtures of Examples 2, 4, 5, and 8, according to an embodiment of the invention.

[0039] FIG. 29 shows a schematic drawing of a FLC Cell fabricated between two ITO coated glass plates (1) and (3), sandwiching a low n ferroelectric liquid crystal (2), according to an embodiment of the invention.

[0040] FIG. 30 shows phase diagrams of the mixtures of 2-(4-(heptyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5O7) and 2-oxo-2-(4-(4-propylcyclohexyl)phenyl)-ethyl 2,3-difluoro-4-(octyloxy)benzoate (PAC-PC3-dFO8), according to an embodiment of the invention.

[0041] FIG. 31 shows phase diagrams of the mixtures of 2-(4-(heptyloxy)phenyl)-2-oxoethyl 4-pentylcyclohexanecarboxylate (PAC-5O7) and 2-oxo-2-(4-(4-propylcyclohexyl)phenyl)-ethyl 3-difluoro-4-(octyloxy)benzoate (PAC-PC3-FO8), according to an embodiment of the invention.

[0042] FIG. 32 shows a contour diagram of calculated n values vs n of reducer and its concentration estimated in linear approximation by Eqn. 3 for binary mixture of PAC-PC and a virtual n reducer, according to an embodiment of the invention.

[0043] FIG. 33 shows a contour diagram of calculated n values vs n of reducer and its concentration estimated in linear approximation by Eqn. 3 for binary mixture of PAC and virtual n reducer, according to an embodiment of the invention.

[0044] FIG. 34 shows plots of the temperature dependency of spontaneous polarization and tilt angle for FLC mixture according to Example 17, according to an embodiment of the invention.

[0045] FIG. 35 shows plots of the temperature dependency of rotational viscosity and helical pitch for the FLC mixture according to Example 17, according to an embodiment of the invention.

[0046] FIG. 36 shows a plot of the dependence of response time vs applied voltage at 21 C. for FLC mixture according to Example 17, according to an embodiment of the invention.

[0047] FIG. 37 shows plots of the time dependence of optical transmittance vs applied voltage for FLC mixture according to Example 17, according to an embodiment of the invention.

[0048] FIG. 38 shows a plot of the temperature dependence of tilt angle for FLC mixtures of Example 18, according to an embodiment of the invention.

[0049] FIG. 39 shows plots illustrating the dependence of response time and transmittance of the cell vs applied voltage for FLC mixtures of Example 18, according to an embodiment of the invention.

[0050] FIG. 40 shows plots of the temperature dependency on the tilt angle for FLC mixtures according to Examples 7 and 8, according to an embodiment of the invention.

[0051] FIG. 41 shows plots of the temperature dependency on the response time for FLC mixtures according to Example 7, according to an embodiment of the invention.

[0052] FIG. 42 shows plots of the temperature dependency on the response time for FLC mixtures according to Example 8, according to an embodiment of the invention.

[0053] FIG. 43 shows a plot of the dispersion of birefringence at 25 C. for a FLC mixture according to Example 14, according to an embodiment of the invention.

[0054] FIG. 44 shows plots of the temperature dependency on spontaneous polarization and response time at Electric field (E)=2 V/m for a FLC mixture according to Example 14, according to an embodiment of the invention.

[0055] FIG. 45 shows plots of the temperature dependency on the tilt angle and response time for FLC mixture according to Example 14, according to an embodiment of the invention.

[0056] FIG. 46 shows plots of the temperature dependency on the tilt angle and rotational viscosity for FLC mixtures according to example 14, according to an embodiment of the invention.

[0057] FIG. 47 shows plots of the temperature dependency on the tilt angles for FLC mixtures according to examples 15 and 16, according to an embodiment of the invention.

DETAILED DESCRIPTION OF THE INVENTION

[0058] Embodiments of the present invention are directed to low birefringence ferroelectric liquid crystals (FLC's) where the birefringence can be adjusted in the range of 0.05-0.014 by controlling the constituents of the material. The FLCs are composed of a plurality of components, where a first component is a thermotropic liquid crystal and a second component is a low birefringence material, such as, but not limited to, a smectic-C material. The low n FLC mixtures eliminates conjugated aromatic molecules comprising two or more than two aromatic or heteroaromatic rings and avoiding extended conjugation with more than one it-bonds, such as, but not limited to, CC, CO, or an ester group. In an embodiment, the chiral fragments of components for the FLC mixtures possess different types of compounds in one or both of the oligomers termini or wings, W1 and/or W2, and the FLC has liquid crystals phases. In an embodiment of the invention the FLC mixture displays a smectic-C phase.

[0059] In embodiments of the invention, the low birefringence ferroelectric liquid crystal mixture that shows birefringence (n) in the range 0.05 to 0.14 comprises a plurality of components, a first component being a thermotropic liquid crystal, possibly a smectic-C phase, while a second component being a low birefringence material with n of 0.02 to 0.1, where either can be a thermotropic liquid crystal, where the low birefringence ferroelectric liquid crystal has the formula:

##STR00002## [0060] where: [0061] n and m are independently 0, 1 or 2; [0062] R1, R2, R3 and R4 are absent or are aromatic, hetero-aromatic, 1,4-cyclohexylidene, 1,4-cyclohexenylidene, 1,3-dioxolane ring or a chiral or achiral polycyclic aliphatic fragment that can be substituted with one or more halogen atoms. Two or more these rings can be condensed with one another, and where one or more H atoms can independently be replaced with F atoms, the H atoms can be in lateral positions; [0063] A1, A2 are single bond, O, S or ester functional group; [0064] B1, B2 and B3 are absent or independently a single CC bond, an ester group, or C(O)CH.sub.2COO, CX.sub.2CH.sub.2COO where X is independently H or halogen atoms, (CH.sub.2).sub.m, or (OCH.sub.2).sub.m where m is 2-11; [0065] W1 and W2 are independently n-alkyl, chiral or achiral alkenyl, or chiral or achiral branched alkyl groups, where at least one CH.sub.2 group is, independently, replaced by CF.sub.2, O, and CHCH groups provided that O atoms are not directly linked to one another.

[0066] In embodiments of the invention, the low-birefringence components of the ferroelectric liquid crystal mixture aromatic or heteroaromatic rings where R1-R4 are not conjugated or cross-conjugated with one another. The low birefringence components of the ferroelectric liquid crystal mixture has aromatic or heteroaromatic ring (R1-R4), independently, in conjugation with no more than one double bond of type CZ, where Z is one of C, N or chalcogen.

[0067] In an embodiment of the invention, the first components of the low birefringence FLC mixture are of smectic-C or SmC* types liquid crystals. Other non-SmC mesogenic components, such as, but not limited to, nematic, cholesteric, SmA, and SmB, can be included to adjust phase transition temperatures or the total n of the mixture, as shown in FIGS. 2-11, whereas their ability to induce ferroelectric properties is indicated in Examples 1-8, below. The content of such non-Smectic-C components for any low birefringence FLC mixture depends on the target application, as indicated in the Examples, below. The mixtures preferably comprises several types of organic compounds, each of them plays a specific role(s) in the target FLC mixture, as indicated in Table 1.

TABLE-US-00001 TABLE 1 General Types of Compounds in Low Birefringence FLC Mixtures Role in Chemical structures(s)* Name of chemical type Abbreviation mixture [00003] [00004] PAC SmC Host [00005] [00006] PAC-PC SmC Host [00007] [00008] CPEH (X = H) CPEF (X = F) n and mp reducer [00009] Demus' esters (n = 0) n-CHA-m n and mp reducer [00010] Bicyclohexane derivatives, BC n and mp reducer [00011] Phenylcyclohexane carboxylic acid esters PCH n and mp reducer [00012] Bicyclohexyl carboxylic acid esters DCHA n and mp reducer [00013] Cholesterol derivatives, A.sub.1 is preferably COO ester group Chol-n n and mp reducer [00014] Cholesterol derivatives, A.sub.1 is preferably COO ester group Chol-CHA-n n and mp reducer [00015] Phenylpyrimidine derivatives, k = 0, 1; R3 is 1,4-phenylene- or cyclohxylene ring PP SmC stabilizer, mp reducer [00016] 1,4-diphenylcyclohexane derivatives, preferably A1 = A2 = COO bridge group, W.sub.1 and/or W.sub.2 is chiral PCP Chiral dopant [00017] 4,4-terphenyl derivatives, preferably A1 = A2 = COO bridge group, W.sub.1 and/or W.sub.2 is chiral TDA Chiral dopant *)W.sub.1 and W.sub.2 are alkyl; A.sub.1, A.sub.2 are single CC bond or oxygen atom

[0068] Preparation of PAC and PAC-PC type liquid crystals can be carried out as in reaction scheme 1.

##STR00018##

[0069] Preparation of CPEH (X.sub.1H) and CPEF (X.sub.1F) type liquid crystals can be carried out as in reaction scheme 2.

##STR00019##

[0070] Preparation of PCP type liquid crystals can be carried out as in reaction scheme 3.

##STR00020##

[0071] Phenacylic esters of cyclohexancarboxylic acids (PAC) were firstly disclosed in Petrov et al. Liquid Crystals, 1999, 26(8), 1141-62, however, the mesomorphic properties did not achieve optimal values of parameters needed for various electro-optical modes, having a SmC phase transition that starts above 100 C. PAC and PAC-PC comprising LC materials, according to an embodiment of the invention, possess a wide range for phase transition of the of SmC phase starting from about 60 to 70 C., rather than the high upper temperature limit of typical SmC phases for PAC and PAC-PC compounds, that occurs above 100 C., as indicated in Table 2 and 3, below. Consistent with the chemical formula of the PAC compounds, the n is around 0.1. In this embodiment of the invention, a large SmC temperature phase transition range and low n occurs. The addition of a chiral component to the body of the PAC allows a chiral mesogens capable of inducing a desirable value of spontaneous polarization, see, for example, entries 1, 2, 4-7, 9-12 in

TABLE-US-00002 TABLE 2 The PAC compounds are core for low birefringence FLC mixtures. Table 2 Phase transitions.sup.a of the PACs of general formula [00021] Entry W1 A.sub.1 X.sup.b W2 Cr C. SmX C. SmB C. SmC C. SmA C. N C. Iso 1 C.sub.6H.sub.13 O C C.sub.5H.sub.11 55.8 83.5 105.2 108 2 C.sub.7H.sub.15 O C C.sub.5H.sub.11 52.5 96.9 110.3 3 C.sub.8H.sub.17 C C.sub.5H.sub.11 88.7 (86.4) 95.6 4 C.sub.8H.sub.17 O C C.sub.4H.sub.9 56 65.2 99.3 110.7 5 C.sub.8H.sub.17 O C C.sub.5H.sub.11 67 104.7 113.7 6 C.sub.8H.sub.17 O C C.sub.6H.sub.13 51 65.4 101 113.4 7 C.sub.8H.sub.17 O C C.sub.6H.sub.13 50.1 60.5 103.3 114.0 8 C.sub.8H.sub.17 O B C.sub.6H.sub.13 63.8 82.5 87.5 94.5 9 C.sub.8H.sub.17 O B C.sub.5H.sub.17 70.8 86.3 89.85 95.5 10 (R)CH(CF.sub.3)C.sub.6H.sub.13 O C C.sub.5H.sub.11 37 42 11 (S)CH.sub.2CHFC.sub.6H.sub.13 O C C.sub.5H.sub.11 71.5 93.5 117.9 12 C.sub.10H.sub.21 O C C.sub.4H.sub.9 60 76.9 104 113.8 13 C.sub.10H.sub.21 O C C.sub.5H.sub.11 50 52 83.2 110.3 116.4 14 C.sub.10H.sub.21 O C C.sub.6H.sub.13 87.5 85.2 112.2 117.2 .sup.aAll phase transitions are obtained in the current invention except Entries 7-9, from Petrov et al.; .sup.bC - is 1,4-trans-disubstituted cyclohexane ring; B is 1,4-disubstituted benzene ring; A.sub.2 is a single bond.

TABLE-US-00003 TABLE 3 Phase transitions.sup.a of the PAC-PCs of general formula [00022] Entry W.sub.1 X.sub.1 X.sub.2 R.sub.1 Cr C. SmX SmC C. SmA C. N C. Iso 1. C.sub.3H.sub.7 F H C.sub.8H.sub.17 68.1 119.3 160 173.3 2. C.sub.3H.sub.7 F F C.sub.8H.sub.17 65 114.0 163.8 3. C.sub.4H.sub.9 F F C.sub.8H.sub.17 57.3 128.6 161.9 4. C.sub.5H.sub.11 F H C.sub.8H.sub.17 57.5 117.8 5. C.sub.5H.sub.11 H F C.sub.8H.sub.17 70.0 100.4 165.2 6. C.sub.5H.sub.11 F F C.sub.8H.sub.17 58 144.5 169 7. C.sub.5H.sub.11 F H (S)-CH.sub.2C*HFC.sub.6H.sub.13 66.5 84.4 168.0 8. C.sub.5H.sub.11 F F C.sub.10H.sub.21 68.8 147.4 163.9

[0072] The PAC series has an orthogonal SmB or another high-ordered phase below SmC (see Table 2). FIG. 7 shows that temperatures of SmB-SmC phase transitions are almost linearly dependent on the individual components, retaining the temperature range of undesirable SmB phase. An additional smectic phase below SmC, in both components, impose certain restrictions on SmC phase temperature range by means of finding an eutectic mixture, as is illustrated in FIGS. 4-9. An almost linear dependence of SmB phase transition temperature on the components concentration is observed. Additionally, the birefringence values of about 0.1 for PAC type compounds requires a thin cell gap of 2.7-2.8 m to achieve the half wave retardation for the green light, and, therefore, n should be further reduced. Therefore, in this embodiment of the invention, components with low n are needed to suppress the n. The following type of compounds can be included as n reducers: (i) esters of 4-alkylcyclohexanecarboxylic acids, as shown in FIG. 12, for their phase diagram see FIGS. 2-5 and (ii) cholesterol derivatives, whose chemical structures are given in FIG. 13, for the phase diagrams see FIG. 6-10.

[0073] Compounds with low n, other than PAC, reveals some degree of an adverse effect regarding SmC phase. In some cases, the SmC phase becomes inferior to a SmB phase and shows further depression with higher concentrations of dopant with lower birefringence, for example, derivatives of cholesterol and cyclohexyl-bicyclohexyl carboxylate. Working mixtures cannot have a total unsaturated dopant content in excess of 10-12 mol. % for compounds DCHA-3 and Chol-SCHA and no more 5 mol. % for Chol-9. Among other dopants, phenylcyclohexane carboxylates (PCH), so-called Demus' esters, appeared to be superior. In another embodiment of the invention, a short SmC phase is mixed with PCH materials, where mixtures of PAC with nematic PCHs are well suited, for example those of FIGS. 2 and 4. Among the cholesterol derivatives, FIG. 5-10, the pentylcyclohexyl carboxylic esters (Chol-5CHA) were found to affect the compounds possessing the SmC* phase, as indicated in FIG. 10. This dopant can be used as a n reducer for FLC mixtures in concentration up to 10-15 mol. % with an acceptable reduction in the upper-temperature limit of SmC*. Two ring phenylpyrimidines (90-PP-O8) were found to be effective SmB suppressor, as shown in FIG. 14.

[0074] The trend for SmC-SmA transitions is roughly that of the corresponding phase transitions of individual components, and remains sufficiently high within the entire range of concentrations. However, because of rather a high birefringence of phenylpyrimidines, about 0.14, its content should not exceed 40 mol. %, and is preferably below 20 mol. % to have appropriate n values for working mixtures.

[0075] Most electro-optical effects for ferroelectric liquid crystals have different requirement for p.sub.0 and .sub.C, as summarized in Table 4, below. These effects can be controlled by the concentration of chiral components or dopants. Furthermore, dopants having a large transverse dipole directly attached to a chiral center provide sufficiently large pitches. To this end, many compounds according to embodiments of the invention, include, but not limited to, polar units like C*F, C*CF.sub.3, C*OC, where C* denotes asymmetric, chiral carbon atom. In an embodiment of the invention, cholesterol derivatives that do not possess C*F, C*CF.sub.3 fragments, do not induce any significant spontaneous polarization or small helical pitch to the FLC mixture when these compounds are used as n reducers in the current invention.

TABLE-US-00004 TABLE 4 Pitch (p.sub.0) and tilt angle (.sub.C) for ferroelectric liquid crystals of different modes. Surface stabilized Deformed helix Electrically suppressed ferroelectric liquid ferroelectric liquid helix ferroelectric liquid Properties crystal (SSFLC) crystals (DHFLC) crystals (ESHFLC) Tilt angle () 22.5 45 22.5 Pitch (nm) >3000-4000 nm < (wavelength of the Comparable to the cell much larger than visible light) much gap the cell gap smaller than the cell gap

[0076] For helix formation, lower values of HTP are typical for mono-substituted dopants that contain a single chiral fragment at one of the terminal positions of dopant molecule. With respect to the chemical structure of the chiral fragment, according to an embodiment of the invention, structures can be ranked in the sequence C*F<C*OC<C*CF.sub.3.

[0077] Typically, .sub.C values increase with concentration of chiral dopant (CD) often reaching saturation at a CD level specific for each selected pairs of CD-FLC host. In general, the chemical structure of the CDs effect on the .sub.C value varies by the chemical class. In an embodiment of the invention, different types of chiral dopants effect the smectic tilt angle in the proposed FLC host where: small angles (.sub.C<10) are induced by compounds bearing one chiral fragment, preferably a C*F fragment and useful for fine adjustment of smectic tilt angles that are induced by other dopants; large angles (.sub.C>30) are induced using chiral dopants having three-ring cores with two chiral fragments derived from 2-CF.sub.3-1-alkanols; and intermediate angles (209, for example 22.5) that are induced with combinations of two types dopant for larger and smaller angles or using a PCP type dopant esterified with chiral 2-octanol or other C.sub.4-C.sub.16 chiral alcohol. The required amount of chiral component is similar to the content of non-chiral constituents, which effects phase transition and n values of the FLC materials. Surprisingly, for example, phenacylic ester bearing a chiral 2-fluorooctanol group shows a mesophase sequence similar to its non-chiral analogs, as shown in FIG. 15 and phase diagram for the FLC materials in FIGS. 16-21. It can be seen that the lowest melting point on the phase diagram of FIG. 15 occurs at a relatively high concentration of chiral dopant, about 75 mol %. On the other hand, other types of the chiral dopant suppress the SmC* phase even when the CD show mesogenic phases, for example, the mesogenic compound PCP-S2F8 affects the SmC* stronger than does the non-mesogenic (PAC-5-SCF3-7), as indicated in FIGS. 11 and 22.

[0078] The electro-optics of the low n FLC has been studied in different electro-optical modes. The mixture number 7-191-M3, shown in Example 8, below, was infiltrated in the liquid crystals cell with planar alignment and thickness 3 m. The cell was placed between the crossed polarizer and switching time was determined as a function of the applied voltage, and the measured n for mixture 7-191-M3 is about 0.110. The voltage dependence of the switching time is shown in FIG. 23. The switching time increases with applied voltage to a peak voltage followed by a decrease in the response time with greater voltage. The presence of the peak in the electro-optical response curve, which represents the electric field strength required to unwind the FLC helix, confirms that the cell infiltrated with 7-191-M3 show an electrically suppressed helix ferroelectric liquid crystal (ESHFLC) mode. The optical micro-photo graph has been shown in Fig. Error! Reference source not found.24, which resembles a typical ESHFLC mode. FIG. 25 shows photographs of a display cell of the ESHFLC mode infiltrated with the low n ESHFLC mixture 7-191-M3 where the bright and dark states provide a high contrast. In contrast, the mixture number 7-130-M3 shown in the example 5, in a similar cell, shows the typical characteristics of a surface stabilized ferroelectric liquid crystal mode with measured n of 0.109, as indicated in FIG. 26. The response time decreases with increasing driving voltage without displaying a peak that reflects suppression of the FLC helix by the cell surface. The optical microscopic image, as shown in FIG. 27, has the typical optical texture for the SSFLC mode.

[0079] The FLC mixture can display a tilt angle that varies with temperature, as illustrated in FIG. 28 for two mixtures, according to an embodiment of the invention. The variability of the tilt angle, pitch, response temperature range, and low n makes these FLC mixtures applicable for cells for displays and other photonic devices. FIG. 29 shows a FLC cell, according to an embodiment of the invention, where the cell includes at least one transparent electrode, such as an ITO glass.

[0080] In an embodiment of the invention, PAC and PAC-PC type FLC mixtures display a n value of 0.105 to 0.12, which are the lowest n for a wide range of SmC based on the climatic f. These types of host components are summarized in Table 5, below. The PAC and PAC-PC type FLC mixtures can have SmC ranging from 34-48 to 90-140 C. In an embodiment of the invention, the SmC range can be 48 to 90-92 C. These mixtures easily overcool, up to room temperature, revealing a monotropic SmB phase or a higher order phase below the SmC phase. The SmB-SmC phase transitions are almost linearly dependent on the individual components.

TABLE-US-00005 TABLE 5 Main properties and features of phenacylic esters (PAC and PAC-PC) of current invention Compounds/Phase sequence and range of temperatures Pros Cons Features [00023] Cheap synthesis Have rather low n: 0.105 in the FLC Manifests of SmB phase: it is difficult to suppress Favourable to induce moderate values of smectic mixtures it does not allow prepara- tilt angle, .sub.c: 15-30 Do not increase tion of eutectic mixtures viscosity too much with marked depression in the FLC mixutres of melting point. Have not high enough thermal stability of SmC - not enough amount of additional n reducer can be added. [00024] Very high thermal stability of SmC Robust to introducing Multistep synthesis Have higher n than for PAC series: ~0.12 in the When dominate in FLC mixtures, has trend to induce tens % of n reducers FLC mixtures rather high smectic Do not form SmB Prone to increase viscosity tilt angle, .sub.c, up to phases and often in FLC, especially at high 47. suppress them in the their content FLC mixtures

[0081] In the next embodiment of the invention, the PAC-PC types of compounds do not possess a SmB phase, moreover, in the mixtures with PAC this unwanted SmB is fully suppressed, as can be seen in FIGS. 30 and 31. Representatives of PAC-PC series have a wide-range SmC host, from 35 to 140 C., as in Example 13, below. However, if the content of PAC-PC compounds in the FLC host exceeds 50% with respect to the PAC, the viscosity and smectic tilt angle .sub.c increase.

[0082] In an embodiment of the invention, another n and melting point reducers is included. By equation 3, above, an estimate of the content of various n reducers in binary mixtures with PAC or PAC-PC needed to reduce the inherent birefringence of the host from 0.105-0.12 to a target n value of 0.1 is shown in FIGS. 32 and 34, where the bottom horizontal lines represent the lowest n values (0.03 and more realistic 0.04) of currently known n reducers among calamitic LC. As can be seen in FIGS. 33 and 34, with n reducers of 50 or 60 mol. % in combination with the lowest birefringent dopant provides n values of mixtures that are, at most, 0.066 or 0.06, respectively. Any components that destroy the LC phase, in particular the SmC, also can reduce the order parameter of the LC phase and display a deviation from linear dependency of Eqn. 3, allowing the experimentally measured n to be smaller than the estimated value.

[0083] A representative list of compounds that can be used as n reducers is given in Table 1, where there are almost no LC compounds that combine a SmC phase with n values less than 0.08. Therefore, any such compounds chosen as n reducer will suppress the SmC phase of the host, and limit their content to 50 or, in the best case, 60 mol. %. All tested compounds showing lower n than PAC or PAC-PC reveal adverse effect on the SmC phase. In some cases, the SmC phase becomes inferior to the SmB phase and shows greater depression at high concentrations of dopant.

[0084] To facilitate comparison and selection of additives for basic SmC hosts comprising PACs and/or PAC-PCs, the influence of the dopants on the SmC and SmB phase transition temperatures for the mixtures is estimated by the slope of the corresponding line on the phase diagrams, as indicated in Table 6, below.

TABLE-US-00006 TABLE 6 Influence of the dopants on SmC and SmB phase transition temperatures in the mixtures PAC- PAC- PAC PC PC Chemical structure of dopants, abbreviation SmC.sup.*) SmB.sup.*) SmC.sup.*) mix [00025] CPEH 13.6 4.7 16.2 32.0 [00026] 10.5 24.00 [00027] 4.00 14.80 10.0 27.00 [00028] CPEF 11 [00029] 10.50 11.00 [00030] CHA-26 CHA-46 15.90 12.00 16.40 4.50 [00031] BC mix 43.25 [00032] [00033] 19.00 [00034] 22.00 20.11 [00035] 30.00 27.50 [00036] DCHA-3 9.7 11.7 [00037] [00038] 39 24 [00039] 26.50 18.70 [00040] 9.000 21.000 8.400 [00041] 16.500 22.000 17.100 10.700 [00042] [00043] 24.11 [00044] 19.30 4.60 [00045] 24.125 .sup.*)Decreasing of the corresponding phase transition on temperature ( C.) per 10 mol. % of dopant added to PAC, PAC-PC, or PAC-PC mixtures prepared according to Example 13, below

[0085] In general, SmC phase thermal stability of PAC type of materials is sensitive to some dopants required to improve n, mp, or other parameters. The relatively low concentrations of about 15-20% of bicyclohexyl carboxylate (DCHA-3) or cholesterol esters can fully suppress SmC phases, as indicated in FIGS. 5-7 and 10. Therefore, the total content of dopant cannot exceed 10-12 mol. % for compounds DCHA-3 and Chol-5CHA and no more than 5 mol. % for Chol-9. The SmC phase in the PAC-PC series appears more robust to these n reducers, and so, up to 25%, and, for several cases, up to 30 mol %, of dopant can be added.

[0086] Among other dopants, those which suppress SmB phase to a greater extent than SmC phase are useful. As can be seen from the Table 6, these requirements are satisfied using CPEH, short-tail Demus esters, and some cholesterols esters. These dopants can be used as n reducers for FLC mixtures in concentration up to 10-15 mol. % with an acceptable reduction in the upper-temperature limit for the SmC*. The two rings phenylpyrimidines are effective SmB suppressors, see for example, FIG. 14 using 9O-PP-O8 as an example. Because of the high birefringence of phenylpyrimidines (0.14) their content should be limited to 40 mol. %, such as 20 mol. %, in order to get an appropriate n values for working mixtures.

[0087] A chiral dopant (CD), being necessary to induce ferroelectric properties in a FLC host and the CD affects the SmC phase transitions. Phenacylic esters bearing the chiral 2-fluorooctanol group shows mesophases sequence similar to their non-chiral analogs, and the phase diagram pattern, see FIG. 15 and FIG. 4. The lowest melting point on the phase diagram of FIG. 15 is observed at relatively high concentration of chiral dopant, about 75 mol. %. The chiral dopant, derivative of terphenyldicarboxylic acid, which is widely used in FLC mixtures of higher n, is not effective for the FLC with low n, according to embodiments of the invention, as the resulting birefringence is too high, and additionally chiral dopant essentially reduces the SmC* upper limit and does not suppress fully the SmB phase.

[0088] Most electro-optical effects for the ferroelectric liquid crystals have different requirement for p.sub.0 and .sub.C, as summarized in Table 7 below, which can be controlled by the types and/or concentration of the chiral dopants.

TABLE-US-00007 TABLE 7 Variation for Main Parameters in Current Electro-Optical Effects in FLCs Electrically Surface stabilized FLC suppressed helix FLC Deformed helix FLC Properties mode (SSFLC) (ESHFLC) (DHFLC) Tilt angle () 22.5 22.5 35-45 Temperature Strongly affects the Strongly affects the No or weakly affects dependence of optical contrast of the optical contrast of the the optical contrast tilt angle device. device. of the device. Pitch (nm) >much larger than the Comparable but Much smaller than cell gap (~10-20 m) smaller than the cell the cell gap < gap (~0.3-2 m) (wavelength of the visible light) (<300 nm) Ps, nC/cm.sup.2 Sufficiently Small Sufficiently Small Sufficiently large Anchoring Should be stronger than Should be comparable The elastic energy of energy the elastic energy of the but smaller than the the helix is very limitations helix elastic energy of the high. helix

[0089] Dopants with rather large transverse dipole directly attached to the chiral center provide sufficiently large Ps. This is the case for most dopants described herein, but the invention is not limited to typical polar units, such as C*F, C*CF.sub.3, C*OC, where C* denotes an asymmetric chiral carbon. Cholesterol derivatives those do not possess C*F, C*CF.sub.3 fragments do not induce either a significant spontaneous polarization or a short helical pitch in the FLC mixture and these compounds are used as n reducers.

[0090] The ability for helix formation is indicated by lower values of HTP, which is typical for mono-substituted dopants, those containing only one chiral fragment at one of the terminal positions of a dopant molecule. With respect to the chemical structure of the chiral fragment, the sequence C*F<C*OC<C*CF.sub.3 correlates to increasing HTP.

[0091] Typically, the .sub.C value increases with concentration of CD, often reaching saturation of CD content specifically for a given selected pair with a CD-FLC host. In general, the influence of the chemical structure of the chiral dopant on .sub.C values varies among chemical classes. The smallest angles, .sub.C<10, are induced by compounds bearing one chiral fragment, preferably C*F. These dopants are useful for fine adjustment of smectic tilt angles induced by other dopants. The intermediate tilt angles, around 20 including 22.5 , can be induced by combinations of the two types dopant mentioned above or with one dopant of the PCP type esterified with chiral 2-octanol. The highest angles, .sub.C>30, can be induced using chiral dopants having a three-ring core and two chiral fragments, such as, but not limited to, fluorine-containing CDs, such as, but not limited to derivatives of 2-CF.sub.3-1-alkanols.

[0092] The electro-optics of the low n FLCs, as illustrated Examples 2-5, 7-8 and 14, below, find application in so-called low-twisted FLC modes, such as SSFLC or ESH modes, whereas Examples 15-18, below 17-20 are useful for DHFLC's as indicated in FIGS. 34-39. The DHF mixtures include a higher content of CD to obtain a sufficiently tight helical pitch to provide Bragg diffraction in wavelengths shorter than visible range.

[0093] For a mixture, such as that of Example 5, below, filled in a similar cell as that disclosed, above, the typical characteristics of the surface stabilized ferroelectric liquid crystal mode are displayed with a measured n of 0.109, as illustrated in FIG. 26. The response time decreases with increasing driving voltage without manifesting any sign of a peak in the response time that reflects a suppression of the FLC helix by the cell surface. Therefore, the response time simply decreases with the applied voltage. The optical microscopic image, shown in FIG. 27, shows the typical optical texture for the SSFLC mode.

[0094] For a mixture, such as that of Example 8, below, was infiltrated in the liquid crystals cell with planar alignment and thickness 3 m. Thereafter, the cell was placed between crossed polarizers and the time of application of current, as a function of the applied voltage, was studied to understand the nature of the electro-optical mode. The measured n for the mixture is 0.110. The voltage dependence of the time under current, the switching on time, is shown in FIG. 23. The switching on time, first, increases with applied voltage and shows decreases after the peak response. The presence of the peak in the electro-optical response curve, which represents the electric field strength required to unwind the FLC helix, confirms that the cell with the mixture show an electrically suppressed helix ferroelectric liquid crystal (ESHFLC) mode. The optical micro-photo graph shown in FIG. 24 resembles a typical ESHFLC mode. The photographs of a display cell of the ESHFLC mode infiltrated with the low n ESHFLC mixture is shown in FIG. 25. The bright and dark state show high contrast.

Materials and Methods

[0095] Synthesis

[0096] Demus esters (n-CHA-m), Bicyclohexane derivatives (BC), Phenylcyclohexane carboxylic acid esters (PCH), Bicyclohexyl carboxylic acid esters (DCHA), Phenylpyrimidine derivatives (PP) Cholesterol derivatives (Chol-n) are commercially available materials and used as is. The 4,4-terphenyl derivatives, preferably A.sub.1=A.sub.2=COO bridge group (TDA) were obtained as it was described in Pozhidaev et al Journal of Materials Chemistry C, 2016, 4, 10339-46.

[0097] The synthesis of phenacylic esters of PAC and PAC-PC types, were carried out as indicated in Scheme 1, above.

[0098] The synthesis of phenacylic esters of type PAC and PAC-PC were carried out in the manner disclosed in Huang et al. Synthetic Communications, 1988, 18(10), 1167-70, except for the isolation and purification. A mixture of a corresponding carboxylic acid (5.5 mmol), phenacyl bromide (5 mmol), potassium carbonate (5.5 mmol), polyethylene glycol (M=4000, 1.1 mmol) and acetonitrile (15 ml) was stirred at room temperature for 20 min and refluxed about 1.5 hours. The reaction mixture was evaporated to dryness at reduced pressure, suspended in 50 mL of 1:1 v/v benzene-hexane mixture, filtered through short pad of silica gel and washed twice with 30 ml of the same solvent, evaporated to dryness, crystallized twice from acetonitrile or 2-propanol and dried in vacuo. The products were dissolved in a minimal volume of benzene and filtered through short path of silica gel on a PTFE sub-micro filter (0.2 m pore size). The silica gel was washed with benzene, evaporated to dryness under a steam of nitrogen, and dried in vacuo. Thermal characteristics and phase sequences for these obtained compounds are given in Tables 2 and 3, above.

Synthesis of 1-aryl-2-bromo-1,1-difluoroethanes

[0099] To degassed the solution of corresponding phenacyl bromide (29.9 mmol) in 50 mL of dry benzene under N.sub.2 atmosphere, 6 mL of DAST (44.9 mmol) was added at ambient temperature. The mixture was stirred for 20 hours, then heated up to 45 C. for 20 hours till reaction was completed (monitored by GC-MS). Then the mixture of 20 g of NaHCO.sub.3 in 200 mL of ice-water was added, organic materials was extracted with DCM, washed with water, dried over Na.sub.2SO.sub.4, filtered and evaporated to dryness. The oil residue comprising 95-96% of a main component by GC-MS, was used for the next step without additional purification.

Synthesis of 1-aryl-1,1-difluoro-2-hydroxyethanes

[0100] A mixture of crude 2-bromo-1,1-difluoro-1-arylethanes (21 mmol), 8.4 g of KOAc (86 mmol), 4.1 g 18-crown-6 (16 mmol) in dry DMF was refluxed till reaction was completed as indicated by GC-MS analysis, typically 12-16 hours. The reaction mixture was evaporated to dry at reduced pressure, dissolved in 130 mL of EtOH, and a solution of 8 g NaOH in 40 mL water was added. The mixture was refluxed for 30 min and the EtOH was evaporated. To the residual water was added HCl and the pH was adjusted to 3-4. Organic materials were extracted with DCM, washed with water, dried over Na.sub.2SO.sub.4, and evaporated to dryness. The product was isolated by column chromatography on silica gel using hexane-ethyl acetate mixture as eluent. After evaporation the semi-solid product was purified by crystallization from MeCN. Yield 30-35%.

Synthesis of 1-aryl-2-bromoethanes

[0101] To a degassed solution of the corresponding phenacyl bromide (2.55 mmol) in 10 mL of dry trifluoroacetic acid under N.sub.2 atmosphere was added 1.02 mL of triethylsilane (6.37 mmol) at 5-10 C. The mixture was stirred for 25 hours, then heated to 60 C. for 30 min. A 100 mL portion of ice-water was added, and organic materials was extracted with DCM, washed with water, dried over Na.sub.2SO.sub.4, filtered, and evaporated to dryness. The oil residue, having 86-88% of a main component by GC-MS analysis, was purified by flash chromatography on silica gel/hexane and used without additional purification.

Synthesis of 1-aryl-2-hydroxyethanes

[0102] A mixture of the crude 2-bromo-1-arylethanes, 1.0 g of KOAc (10.2 mmol), 0.6 g PEG-4000 in 40 mL of dry DMF was refluxed till reaction was completed as monitored by GC-MS, typically 16 hours. The reaction mixture was evaporated to dryness at reduced pressure, purified by flash-chromatography on silica gel/benzene-hexane (1:1 v/v), evaporated to dryness, dissolved in 25 mL of EtOH and a solution of 2.5 g KOH in 20 mL of water was added. The mixture was refluxed for 2 hours and cooled. EtOH was evaporated to residue water and hydrochloric acid was added to achieve a pH 3-4. Organic materials were extracted with DCM, washed with water, dried over Na.sub.2SO.sub.4, and evaporated to dryness. The product was isolated by column chromatography on silica gel using hexane as eluent. After evaporation of the oil, product was crystallized, with a yield 85% from the phenacyl bromide.

Esterification of 1-aryl-2-hydroxyethanes or 1-aryl-1,1-difluoro-2-hydroxyethanes, General Procedure

[0103] To an ice-water cooled mixture of 0.66 mmol of the corresponding 1-aryl-2-hydroxyethane, 0.68 mmol of the appropriate carboxylic acid, and a few mg of DMAP in 6 mL of dry DCM, a solution of 165 mg of DCC (0.79 mmol) in 2 mL of DCM was added dropwise. The reaction mixture was stirred overnight, filtered through a short path of silica gel, washed with 15 mL of DCM, and evaporated to dryness. The residue was crystallized from acetonitrile or 2-propanol and dried in vacuo. The product was dissolved in a minimal volume of benzene and filtered through a short path of silica gel on a PTFE 0.2 m pore size filter. The silica gel was washed with benzene, evaporated to dryness under a steam of nitrogen and dried in vacuo. Thermal characteristics and phase sequences for thus obtained compounds are given in Table 5, below.

TABLE-US-00008 TABLE 5 Phase transition temperature of cyclohexylphenylethyl esters CPEH (X = H) and CPEF (X = F) [00046] [00047] [00048] W.sub.1 A.sub.1 X X.sub.1 X.sub.2 A W.sub.2 A.sub.2 Cr N Iso 5 H Ch 5 111.2 5 F Ch 5 85.5 5 F H H Ph 8 56 () 45 (37) 5 H H F Ph 8O O 5 H F F Ph 8O O 74.8 88.1 5 F H F Ph 8O O 56 () 56 (35) 5 F F F Ph 8O O 60 () 58 (45)

[0104] Synthesis of cholesterol trans-4-alkylcyclohexane carbxylates was performed essentially as described for esterification of 1-aryl-2-hydroxyethanes, above.

[0105] Cholesterol trans-4-pentylcyclohexane carbxylates was obtained in 56% yield and showed the following phase transitions: Cr 117-118 C. SmA. 208.5 N* 237 Iso.

Synthesis of Esters of 1,4-bis(4-carboxyphenyl)cyclohexane (PCP)

Synthesis of 1,4-diphenylcyclohexane

[0106] To a refluxed solution of phenylmagnesium bromide, obtained from 9.0 ml bromobenzene (86.1 mmol) and 2.8 g Mg (115 mmol) in 110 ml THF, was added dropwise the solution of 10 g 4-phenylcyclohexanone (57.4 mmol) in 40 mL dry THF for 40 min. The reaction mixture was refluxed for 6 hours, cool down to ambient temperature and poured into 50 mL of AcOH in ice water. Organic materials were extracted into EtOAc and evaporated to dryness. The solid residue was refluxed with 0.2 g of 4-toluensulfonic acid in 250 mL toluene using a Dean-Stark water trap for 10 hours, cooled, filtered through a short path of silica gel, and evaporated to dryness. Solid residue was dissolved in 150 mL of dry THF, flashed with N.sub.2, 0.5 g of 10% Pd/C was added, and he mixture hydrogenated till H.sub.2 absorption was completed, approx. for 15 h. Catalyst was filtered, washed with toluene, filtrate was evaporated to dryness and solid residue was crystallized from 200 mL EtOH to furnish 4.97 g of needle crystals, yield 37%.

Synthesis of 1,4-bis(4-carboxyphenyl)cyclohexane

[0107] To a suspension of 4.5 g anhydrous AlCl.sub.3 (34 mmol) cooled to 2 C. in 20 ml DCM 6.0 mL of (COCl).sub.2 (69 mmol) was added at that temperature. The reaction mixture was stirred for 10 min and solution of 1,4-diphenylcyclohexane in 70 ml DCM was added drop wise for 1 hour at temperatures below 5 C. and stirred overnight. The reaction mixture was poured onto 400 g of an ice-HCl mixture, the volatile solvent evaporated, and the solid residue was filtered, washed with water, and dried. The product was purified using extraction with hot acetonitrile in a Soxlet apparatus, the extract was cooled, and fine crystal filtered and dried. Yield 3.98 g.

Esterification of 1,4-bis(4-carboxyphenyl)cyclohexane with S-2-octanol, General Procedure

[0108] A mixture of 0.895 g of 1,4-bis(4-carboxyphenyl)cyclohexane (2.5 mmol) and a few drops of DMF was refluxed in 15 mL of SOCl.sub.2 until the solution become homogeneous and an additional 3 hours. Then reaction mixture was evaporated to dryness, the residue dried in vacuo, dissolved in 30 mL of refluxing toluene to which a solution of 2 mL of S-2-octanol (12.6 mmol) was added. A solution of 3 mL pyridine (22 mmol) in 9 mL of toluene was added. The reaction mixture was refluxed for an additional 5 hours, filtered through a short path of silica gel, the silica washed with toluene (310 mL), and the combined filtrate was evaporated to dryness. The solid residue was crystallized twice from acetonitrile to yield 0.42 g (31%) of colorless fine crystals, mp 68.4-69.4 C.

[0109] In like manner, 0.40 g of 1,4-bis(4-(2-flouro-1-octylcarbonyloxyphenyl)cyclohexane was obtained in a 35% yield from 0.9 g of S-2-flouro-1-octanol and 0.644 g of 1,4-bis(4-carboxyphenyl)cyclohexane. Phase transitions are Cr 72.6 SmA 111.0 Iso.

[0110] In like manner, 0.25 g of 1,4-bis(4-(2-trifluoromethyl-1-heptylcarbonyloxyphenyl)-cyclohexane was obtained in a 40% yield (mp 54.1-54.9 C.) from 0.307 g of 1,4-bis(4-carboxyphenyl)cyclohexane and 0.870 g of S-1,1,1-trifluoro-2-octanol 0.25 g of 1,4-bis(4-(2-trifluoromethyl-1-heptylcarbonyloxyphenyl)cyclohexane.

EXAMPLES OF FLC MIXTURES

Example 1

Mixture 7-110-M2

[0111]

TABLE-US-00009 Chemical structure of components Wt % [00049] 81.6 [00050] 18.4 Estimated n 0.119 Phase transitions Iso 104.1 SmA 86.0 SmC* 36 SmB

Example 2

Mixture 7-119-M1 of the Following Components

[0112]

TABLE-US-00010 Chemical structure of components Wt % [00051] 51.2 [00052] 35.4 [00053] 13.4 Estimated n 0.113 Phase transitions Iso 101.2 SmA 76.0 SmC* 30 Cr *.sup.)Temperature dependencies of these parameters are shown in FIGS. 28.

Example 3

Mixture 7-119-M3 of the Following Components

[0113]

TABLE-US-00011 Chemical structure of components [00054] 52.4 [00055] 36.1 [00056] 11.5 Estimated n 0.102 Phase transitions Iso 99.0 SmA 67.4 SmC* 33 Cr

Example 4

Mixture 7-130-M2

[0114]

TABLE-US-00012 Chemical structure of components Wt % [00057] 47.8 [00058] 33.0 [00059] 1.3 [00060] 1.1 [00061] 1.2 [00062] 6.6 [00063] 8.9 Estimated n 0.113 Phase transitions Iso 102.0 SmA 78.5 SmC* 35 Cr *.sup.)Temperature dependencies of these parameters are shown in FIG. 28.

Example 5

Mixture 7-130-M3

[0115]

TABLE-US-00013 Chemical structure of components [00064] 47.3 [00065] 32.6 [00066] 1.3 [00067] 1.1 [00068] 1.2 [00069] 6.5 [00070] 10 Estimated n, 0.115 Phase transitions Iso 102.0 SmA 78.5 SmC* 35 Cr *.sup.)Temperature dependencies of these parameters are shown in FIG. 28.

Example 6

Mixture 7-130-M4

[0116]

TABLE-US-00014 Chemical structure of components Wt % [00071] 48.1 [00072] 33.2 [00073] 1.3 [00074] 1.1 [00075] 1.2 [00076] 6.6 [00077] 8.5 Estimated n 0.106 Phase transitions Iso 98.3 SmA 72.5 SmC* 33.5 Cr

Example 7

Mixture 7-191-M2

[0117]

TABLE-US-00015 Chemical structure of components Wt % [00078] 55.8 [00079] 4.1 [00080] 4.5 [00081] 2.2 [00082] 4.9 [00083] 4.3 [00084] 4.8 [00085] 10.2 [00086] 9.2 Estimated n 0.115 Phase transitions Iso 90 SmA 65.0 SmC* 16 Cr *.sup.)Temperature dependencies of these parameters are shown in FIGS. 40, and 41.

Example 8

Mixture 7-191-M3

[0118]

TABLE-US-00016 Chemical structure of components Wt % Mol % [00087] 54.8 54.1 [00088] 4.6 5.4 [00089] 5.0 5.4 [00090] 2.5 2.7 [00091] 5.4 6.2 [00092] 4.7 5.0 [00093] 5.3 5.3 [00094] 11.3 10.9 [00095] 6.4 5.0 Estimated n 0.109 Phase transitions Iso 89 SmA 67.0 SmC* 19 Cr *.sup.)Temperature dependencies of these parameters are shown in FIGS. 40, and 41.

Example 9

Mixture 7-213-M3

[0119]

TABLE-US-00017 Chemical structure of components Wt % Mol % [00096] 32.8 31 [00097] 17.2 15.5 [00098] 13.2 15.5 [00099] 27.4 31 [00100] 9.4 7.0 Estimated n 0.088 Phase transitions Iso 86 SmA 61.0 SmC* 14 Cr

Example 10

Mixture 7-022-M6

[0120]

TABLE-US-00018 Chemical structure of components Wt % [00101] 33.7 [00102] 16.8 [00103] 39.0 [00104] 10.5 Phase transitions Iso 66 SmA 48 SmC* Estimated n 0.119 c at 21 C. 15 Ps, nC/cm.sup.2, at 26 C. 8.5

Example 11

Mixture 7-029-M2

[0121]

TABLE-US-00019 Chemical structure of components Wt % [00105] 30.5 [00106] 15.3 [00107] 35.3 [00108] 18.9 Phase transitions Iso 67 SmA 49 SmC* Estimated n 0.131 Measured n 0.100 c at 23 C. 19.5 Ps, nC/cm.sup.2, at 23 C. 92

Example 12

Mixture of PAC Homologues

[0122]

TABLE-US-00020 Chemical structure of components Mol. % [00109] 40 [00110] 60 Phase transitions Iso 110.6 SmA 90.5 SmC (38.7 SmB) 49 Cr

Example 13

Mixture of PAC-PC Compounds

[0123]

TABLE-US-00021 Chemical structure of components Mol. % [00111] 25 [00112] 37.5 [00113] 37.5 Phase transitions Iso 165.5 N 144.2 SmA 139.8 SmC 35 Cr

Example 14

[0124]

TABLE-US-00022 Chemical structure of components Wt % [00114] 33.3 molar % [00115] 33.3 molar % [00116] 16.7 molar % [00117] 16.7 molar % Phase transitions Iso 73 SmA 53 SmC* 19 Cr Measured n 0.1* c, degree, at 29 C. 22 * Ps, nC/cm.sup.2, at 29 C. 17.5* .sub.on, s, at 29 C. 840* *.sup.)For temperature dependencies of these parameters are shown in FIGS. 43-45.

Example 15

Low-n FLC Mixture for DHF Effect, High Tilt

[0125]

TABLE-US-00023 Chemical structure of components Mol. % [00118] 12.4 [00119] 18.8 [00120] 18.8 [00121] 2.7 [00122] 21.4 [00123] 15.3 [00124] 10.6 Phase transitions Iso 173.3 N* 140.2 SmA 78.8.0 SmC* 19 Cr Estimated n 0.09 c at 21 C..sup.*) 47 .sub.on, s, at 21 C. 6000 .sup.*) Temperature dependencies of these parameter are shown in FIG. 46.

Example 16

Low-n FLC Mixture for DHF effect, High Tilt

[0126]

TABLE-US-00024 Chemical structure of components Mol. % [00125] 16.1 [00126] 24.2 [00127] 24.2 [00128] 3.4 [00129] 11.9 [00130] 9.5 [00131] 10.7 Phase transitions Iso 173.3 N* 140.2 SmA 78.8.0 SmC* 19 Cr Estimated n 0.09 c at 21 C. .sup.*) 47 .sub.on, s, at 21 C. 9000 .sup.*) Temperature dependencies of these parameter are shown in FIGS. 46.

Example 17

Low-n FLC Mixture for DHF Effect

[0127]

TABLE-US-00025 Chemical structure of components Mol. % [00132] 28.6 mol. % [00133] 28.6 mol. % [00134] 14.3 mol. % [00135] 14.2 mol. % [00136] 14.3 mol. % Phase transitions Iso 89 SmA 50.0 SmC* 18 Cr Estimated n 0.115 Measured effective n, at 30 C..sup.*) 0.093 c at 22 C..sup.*) 21.5 Ps, nC/cm.sup.2, at 22 C..sup.*) 38 .sub.on, s, at 22 C..sup.*) 840 .sup.*)Temperature dependencies of these parameters are shown in FIGS. 34-37.

Example 18

Low-n FLC Mixture for DHF Effect 8-050-M6

[0128]

TABLE-US-00026 Chemical structure of components Mol. % [00137] 23 [00138] 34 [00139] 19 [00140] 18 Phase transitions Iso 72 SmA 34.0 SmC* 14 Cr Estimated n 0.117 Measured effective n, at 21 C. 0.097 c at 21 C..sup.*) 13.7 .sub.on, s, at 21 C..sup.*) 80 .sup.*)Temperature dependencies of these parameters are shown in FIGS. 38-39.
All patents, patent applications, provisional applications, and publications referred to or cited herein, supra or infra, are incorporated by reference in their entirety, including all figures and tables, to the extent they are not inconsistent with the explicit teachings of this specification.

[0129] It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application.